Evidence map›Paper›PMID 41417436›Full record

ReviewMolecular biology reports2025

Inflammatory biomarkers in axial spondyloarthritis and the effect of moderate and high-intensity interval training - a narrative review.

Emma Lienesch, Johannes Voß, Åsa Andersson

Abstract readReview
In one paragraph

Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emma LieneschHalmstad University, Halmstad, Sweden.
Johannes VoßInstitute of Sports Medicine and Prevention, Leipzig University, Leipzig, Germany.ORCID http://orcid.org/0009-0000-4399-5480
Åsa AnderssonDept. of Environmental- and Biosciences, FIH, Halmstad University, Halmstad, Sweden. asa.andersson@hh.se.ORCID http://orcid.org/0000-0003-4360-7710

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatic and musculoskeletal diseases pose a significant and increasing global burden, where axial spondyloarthritis (axSpA) shows a prevalence ranging between 0.2% and 1.6% worldwide. Alongside pharmacological treatments, non-pharmacological exercise interventions are a well-established option for axSpA, offering benefits such as improved disease activity, pain, mobility, and overall quality of life. Moderate-intensity training (MIT) is linked to anti-inflammatory effects, while high-intensity interval training (HIIT) shows promising results for cardiovascular health and to reduce systemic inflammation. Current research emphasizes the need to investigate the effects of MIT and HIIT on inflammation, bone remodeling, and tissue repair. Exercise influences inflammatory biomarkers like C-reactive Protein (CRP), Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and calprotectin, though responses vary by intensity, duration, and disease stage. Further studies are crucial to optimize exercise regimens for axSpA patients by comparing moderate- and high-intensity training concerning their effects on selected blood biomarkers. The aim of this review is to summarize results from studies on specific biomarkers after exercise interventions in individuals with axSpA.

Indexed as

Axial SpondyloarthritisBiomarkersHigh-Intensity Interval TrainingC-Reactive ProteinExerciseExercise TherapyHumansInflammationInterleukin-6Leukocyte L1 Antigen ComplexQuality of LifeTumor Necrosis Factor-alphaBiomarkersC-Reactive ProteinInterleukin-6Leukocyte L1 Antigen ComplexTumor Necrosis Factor-alphaAxSpABiomarkersExerciseHigh-intensity interval training (HIIT)Moderate-intensity training (MIT)Physical activity

Identifiers

PMID41417436
PMCPMC12717117

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.